Published in Virology on August 01, 2004
Kaposi's sarcoma-associated herpesvirus ORF57 protein binds and protects a nuclear noncoding RNA from cellular RNA decay pathways. PLoS Pathog (2010) 1.18
Intracellular localization map of human herpesvirus 8 proteins. J Virol (2007) 1.16
Kaposi's sarcoma-associated herpesvirus ORF57 in viral RNA processing. Front Biosci (Landmark Ed) (2009) 1.13
Promoter- and cell-specific transcriptional transactivation by the Kaposi's sarcoma-associated herpesvirus ORF57/Mta protein. J Virol (2007) 1.07
KSHV Rta Promoter Specification and Viral Reactivation. Front Microbiol (2012) 1.04
An integrated approach to elucidate the intra-viral and viral-cellular protein interaction networks of a gamma-herpesvirus. PLoS Pathog (2011) 0.91
Differential role for host translation factors in host and viral protein synthesis during human cytomegalovirus infection. J Virol (2013) 0.84
Extreme dependence of gH and gL expression on ORF57 and association with highly unusual codon usage in rhesus monkey rhadinovirus. J Virol (2008) 0.83
KSHV ORF57, a protein of many faces. Viruses (2015) 0.82
PolyC-binding protein 1 interacts with 5'-untranslated region of enterovirus 71 RNA in membrane-associated complex to facilitate viral replication. PLoS One (2014) 0.80
The Smac mimetic RMT5265.2HCL induces apoptosis in EBV and HTLV-I associated lymphoma cells by inhibiting XIAP and promoting the mitochondrial release of cytochrome C and Smac. Leuk Res (2012) 0.78
ORF57 overcomes the detrimental sequence bias of Kaposi's sarcoma-associated herpesvirus lytic genes. J Virol (2015) 0.76
KSHV and the Role of Notch Receptor Dysregulation in Disease Progression. Pathogens (2017) 0.75
SOCS-1 participates in negative regulation of LPS responses. Immunity (2002) 3.39
Comparison of the complete DNA sequences of the Oka varicella vaccine and its parental virus. J Virol (2002) 2.05
Comparison of varicella-zoster virus-specific immunity of patients with diabetes mellitus and healthy individuals. J Infect Dis (2009) 1.60
NXP-2 association with SUMO-2 depends on lysines required for transcriptional repression. Proc Natl Acad Sci U S A (2006) 1.59
The molecular epidemiology of varicella-zoster virus: evidence for geographic segregation. J Infect Dis (2002) 1.58
Human herpesvirus 6B infection of the large intestine of patients with diarrhea. Clin Infect Dis (2002) 1.40
EphrinB reverse signaling contributes to endothelial and mural cell assembly into vascular structures. Blood (2009) 1.38
Discovery of a second form of tripartite complex containing gH-gL of human herpesvirus 6 and observations on CD46. J Virol (2004) 1.37
Human herpesvirus 6 (HHV-6) is transmitted from parent to child in an integrated form and characterization of cases with chromosomally integrated HHV-6 DNA. J Med Virol (2004) 1.36
Human herpesvirus 6 variant A glycoprotein H-glycoprotein L-glycoprotein Q complex associates with human CD46. J Virol (2003) 1.34
Accumulation of heterochromatin components on the terminal repeat sequence of Kaposi's sarcoma-associated herpesvirus mediated by the latency-associated nuclear antigen. J Virol (2004) 1.34
Classification of HHV-6A and HHV-6B as distinct viruses. Arch Virol (2013) 1.33
Human herpesvirus 6 variant A but not variant B induces fusion from without in a variety of human cells through a human herpesvirus 6 entry receptor, CD46. J Virol (2002) 1.31
Human herpesvirus-6 induces MVB formation, and virus egress occurs by an exosomal release pathway. Traffic (2008) 1.31
Cloning of the varicella-zoster virus genome as an infectious bacterial artificial chromosome in Escherichia coli. Vaccine (2004) 1.27
Intracellular processing of human herpesvirus 6 glycoproteins Q1 and Q2 into tetrameric complexes expressed on the viral envelope. J Virol (2004) 1.20
High incidence of human herpesvirus 6 infection with a high viral load in cord blood stem cell transplant recipients. Blood (2002) 1.17
Role of MyD88 and TLR9 in the innate immune response elicited by serotype 5 adenoviral vectors. Hum Gene Ther (2007) 1.13
Efficient adipocyte and osteoblast differentiation from mouse induced pluripotent stem cells by adenoviral transduction. Stem Cells (2009) 1.12
Hepatitis C virus core protein differently regulates the JAK-STAT signaling pathway under interleukin-6 and interferon-gamma stimuli. J Biol Chem (2003) 1.11
The human herpesvirus 6 U100 gene product is the third component of the gH-gL glycoprotein complex on the viral envelope. J Virol (2003) 1.08
Activation of human herpesvirus 8 open reading frame K5 independent of ORF50 expression. Virus Res (2002) 1.07
Human herpesvirus-6 rep/U94 gene product has single-stranded DNA-binding activity. J Gen Virol (2002) 1.07
Human herpesvirus 6 encoded glycoprotein Q1 gene is essential for virus growth. Virology (2010) 1.07
Poly(ADP-ribose) polymerase 1 binds to Kaposi's sarcoma-associated herpesvirus (KSHV) terminal repeat sequence and modulates KSHV replication in latency. J Virol (2004) 1.05
CD134 is a cellular receptor specific for human herpesvirus-6B entry. Proc Natl Acad Sci U S A (2013) 1.04
Comparison of virus transcription during lytic infection of the Oka parental and vaccine strains of Varicella-Zoster virus. J Virol (2006) 1.01
Hepatitis C virus core functions as a suppressor of cyclin-dependent kinase-activating kinase and impairs cell cycle progression. J Biol Chem (2004) 1.00
Human herpesvirus 6 glycoprotein complex formation is required for folding and trafficking of the gH/gL/gQ1/gQ2 complex and its cellular receptor binding. J Virol (2011) 1.00
Epstein-Barr virus nuclear protein 3C domains necessary for lymphoblastoid cell growth: interaction with RBP-Jkappa regulates TCL1. J Virol (2009) 0.98
Deletion in open reading frame 49 of varicella-zoster virus reduces virus growth in human malignant melanoma cells but not in human embryonic fibroblasts. J Virol (2007) 0.96
Cloning of full length genome of varicella-zoster virus vaccine strain into a bacterial artificial chromosome and reconstitution of infectious virus. Vaccine (2007) 0.95
Contribution of viral and cellular cytokines to Kaposi's sarcoma-associated herpesvirus pathogenesis. J Leukoc Biol (2008) 0.95
Evidence of immunostimulating lipoprotein existing in the natural lipoteichoic acid fraction. Infect Immun (2007) 0.95
Human herpesvirus 6 open reading frame U14 protein and cellular p53 interact with each other and are contained in the virion. J Virol (2005) 0.95
Involvement of p38 signaling pathway in interferon-alpha-mediated antiviral activity toward hepatitis C virus. Biochem Biophys Res Commun (2004) 0.94
Varicella-zoster virus glycoprotein M homolog is glycosylated, is expressed on the viral envelope, and functions in virus cell-to-cell spread. J Virol (2007) 0.94
MicroRNA126 contributes to granulocyte colony-stimulating factor-induced hematopoietic progenitor cell mobilization by reducing the expression of vascular cell adhesion molecule 1. Haematologica (2012) 0.93
Serological and virological studies of Newcastle disease and avian influenza in slaughter-age ostriches (Struthio camelus) in Japan. J Vet Med Sci (2006) 0.93
Human herpesvirus 6 envelope cholesterol is required for virus entry. J Gen Virol (2006) 0.92
Identification of human herpesvirus 6 latency-associated transcripts. J Virol (2002) 0.91
Real-time PCR determination of human herpesvirus 6 antiviral drug susceptibility. J Virol Methods (2006) 0.91
Measurement of varicella-zoster virus (VZV)-specific cell-mediated immunity: comparison between VZV skin test and interferon-gamma enzyme-linked immunospot assay. J Infect Dis (2008) 0.91
Analysis of a neutralizing antibody for human herpesvirus 6B reveals a role for glycoprotein Q1 in viral entry. J Virol (2011) 0.91
Enhancement of immunity against VZV by giving live varicella vaccine to the elderly assessed by VZV skin test and IAHA, gpELISA antibody assay. Vaccine (2003) 0.91
Characterization of varicella-zoster virus-encoded ORF0 gene--comparison of parental and vaccine strains. Virology (2010) 0.90
Efficient adenovirus vector-mediated PPAR gamma gene transfer into mouse embryoid bodies promotes adipocyte differentiation. J Gene Med (2008) 0.90
KSHV RTA induces a transcriptional repressor, HEY1 that represses rta promoter. Biochem Biophys Res Commun (2006) 0.90
Pathogenetic tropism of varicella-zoster virus to primary human hepatocytes and attenuating tropism of Oka varicella vaccine strain to neonatal dermal fibroblasts. J Infect Dis (2003) 0.89
Productive human herpesvirus 6 infection causes aberrant accumulation of p53 and prevents apoptosis. J Gen Virol (2004) 0.89
Poly(gamma-glutamic acid) nano-particles combined with mucosal influenza virus hemagglutinin vaccine protects against influenza virus infection in mice. Vaccine (2009) 0.88
Human herpesvirus 7 U47 gene products are glycoproteins expressed in virions and associate with glycoprotein H. J Gen Virol (2006) 0.87
Role of dendritic cells infected with human herpesvirus 6 in virus transmission to CD4(+) T cells. Virology (2009) 0.87
Development of varicella vaccine. J Infect Dis (2008) 0.87
Generation of a recombinant Oka varicella vaccine expressing mumps virus hemagglutinin-neuraminidase protein as a polyvalent live vaccine. Vaccine (2007) 0.86
Complementation of the function of glycoprotein H of human herpesvirus 6 variant A by glycoprotein H of variant B in the virus life cycle. J Virol (2012) 0.86
Intranasal immunization with a formalin-inactivated human influenza A virus whole-virion vaccine alone and intranasal immunization with a split-virion vaccine with mucosal adjuvants show similar levels of cross-protection. Clin Vaccine Immunol (2012) 0.86
Incidences of Herpes Zoster and Postherpetic Neuralgia in Japanese Adults Aged 50 Years and Older From a Community-based Prospective Cohort Study: The SHEZ Study. J Epidemiol (2015) 0.86
Strong interaction between human herpesvirus 6 and peripheral blood monocytes/macrophages during acute infection. J Med Virol (2002) 0.85
Efficient osteoblast differentiation from mouse bone marrow stromal cells with polylysin-modified adenovirus vectors. Biochem Biophys Res Commun (2008) 0.85
A community-based survey of varicella-zoster virus-specific immune responses in the elderly. J Clin Virol (2012) 0.85
Kaposi's Sarcoma-Associated Herpesvirus Genome Replication, Partitioning, and Maintenance in Latency. Front Microbiol (2012) 0.84
Single dose of inactivated Japanese encephalitis vaccine with poly(gamma-glutamic acid) nanoparticles provides effective protection from Japanese encephalitis virus. Vaccine (2007) 0.84
Human herpesvirus 7 open reading frame U12 encodes a functional beta-chemokine receptor. J Virol (2003) 0.84
Human interleukin-6 induces human herpesvirus-8 replication in a body cavity-based lymphoma cell line. J Med Virol (2002) 0.84
Human herpesvirus-6 infection induces the reorganization of membrane microdomains in target cells, which are required for virus entry. Virology (2008) 0.84
Human herpesvirus 7 open reading frames U12 and U51 encode functional beta-chemokine receptors. J Virol (2005) 0.84
DNA sequence analysis of varicella-zoster virus gene 62 from subclinical infections in healthy children immunized with the Oka varicella vaccine. Vaccine (2008) 0.84
Human herpesvirus 6 ganciclovir-resistant strain with amino acid substitutions associated with the death of an allogeneic stem cell transplant recipient. J Clin Virol (2008) 0.82
Lack of a mechanism for faithful partition and maintenance of the KSHV genome. Virus Res (2006) 0.82
The seroprevalence of human herpesvirus 8 infection in the Thai population. Southeast Asian J Trop Med Public Health (2002) 0.82
The effectors responsible for gastrointestinal nematode parasites, Trichinella spiralis, expulsion in rats. Parasitol Res (2008) 0.81
The transcription factor Gfi1 regulates G-CSF signaling and neutrophil development through the Ras activator RasGRP1. Blood (2010) 0.81
A viral transcriptional activator of Kaposi's sarcoma-associated herpesvirus (KSHV) induces apoptosis, which is blocked in KSHV-infected cells. Virology (2003) 0.81
Varicella-zoster virus ORF49 functions in the efficient production of progeny virus through its interaction with essential tegument protein ORF44. J Virol (2013) 0.81
Highlights from 5th International Conference on HHV-6 and -7. Herpes (2006) 0.80
Poly-γ-glutamic acid nanoparticles and aluminum adjuvant used as an adjuvant with a single dose of Japanese encephalitis virus-like particles provide effective protection from Japanese encephalitis virus. Clin Vaccine Immunol (2011) 0.80
Stress-induced decrease of granule cell proliferation in adult rat hippocampus: assessment of granule cell proliferation using high doses of bromodeoxyuridine before and after restraint stress. Mol Cells (2005) 0.80